Sparrow M - Search Results

1

Hanauer SB, Sparrow M. Hanauer SB, et al. Among authors: sparrow m. Curr Opin Gastroenterol. 2004 Jul;20(4):345-50. doi: 10.1097/00001574-200407000-00008. Curr Opin Gastroenterol. 2004. PMID: 15703663

2

COLAL-PRED Alizyme.

Hanauer SB, Sparrow M. Hanauer SB, et al. Among authors: sparrow m. Curr Opin Investig Drugs. 2004 Nov;5(11):1192-7. Curr Opin Investig Drugs. 2004. PMID: 15573870 Review.

3

Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine.

Sparrow MP, Hande SA, Friedman S, Lim WC, Reddy SI, Cao D, Hanauer SB. Sparrow MP, et al. Aliment Pharmacol Ther. 2005 Sep 1;22(5):441-6. doi: 10.1111/j.1365-2036.2005.02583.x. Aliment Pharmacol Ther. 2005. PMID: 16128682

4

Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine.

Sparrow MP, Hande SA, Friedman S, Cao D, Hanauer SB. Sparrow MP, et al. Clin Gastroenterol Hepatol. 2007 Feb;5(2):209-14. doi: 10.1016/j.cgh.2006.11.020. Clin Gastroenterol Hepatol. 2007. PMID: 17296529

5

Optimizing conventional therapies for inflammatory bowel disease.

Sparrow MP, Irving PM, Hanauer SB. Sparrow MP, et al. Curr Gastroenterol Rep. 2009 Dec;11(6):496-503. doi: 10.1007/s11894-009-0075-6. Curr Gastroenterol Rep. 2009. PMID: 19903426 Review.

6

Long term efficacy and safety of allopurinol and azathioprine or 6-mercaptopurine in patients with inflammatory bowel disease.

Leung Y, Sparrow MP, Schwartz M, Hanauer SB. Leung Y, et al. Among authors: sparrow mp. J Crohns Colitis. 2009 Sep;3(3):162-7. doi: 10.1016/j.crohns.2009.02.003. Epub 2009 Mar 17. J Crohns Colitis. 2009. PMID: 21172265

7

Ustekinumab induction and maintenance therapy in refractory Crohn's disease.

Sandborn WJ, Gasink C, Gao LL, Blank MA, Johanns J, Guzzo C, Sands BE, Hanauer SB, Targan S, Rutgeerts P, Ghosh S, de Villiers WJ, Panaccione R, Greenberg G, Schreiber S, Lichtiger S, Feagan BG; CERTIFI Study Group. Sandborn WJ, et al. N Engl J Med. 2012 Oct 18;367(16):1519-28. doi: 10.1056/NEJMoa1203572. N Engl J Med. 2012. PMID: 23075178 Free article. Clinical Trial.

8

Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis.

Sandborn WJ, Feagan BG, Wolf DC, D'Haens G, Vermeire S, Hanauer SB, Ghosh S, Smith H, Cravets M, Frohna PA, Aranda R, Gujrathi S, Olson A; TOUCHSTONE Study Group. Sandborn WJ, et al. N Engl J Med. 2016 May 5;374(18):1754-62. doi: 10.1056/NEJMoa1513248. N Engl J Med. 2016. PMID: 27144850 Free article. Clinical Trial.

9

Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study).

Friedman AB, Brown SJ, Bampton P, Barclay ML, Chung A, Macrae FA, McKenzie J, Reynolds J, Gibson PR, Hanauer SB, Sparrow MP. Friedman AB, et al. Among authors: sparrow mp. Aliment Pharmacol Ther. 2018 Apr;47(8):1092-1102. doi: 10.1111/apt.14571. Epub 2018 Feb 21. Aliment Pharmacol Ther. 2018. PMID: 29468701 Clinical Trial.

10

Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.

Sandborn WJ, Feagan BG, D'Haens G, Wolf DC, Jovanovic I, Hanauer SB, Ghosh S, Petersen A, Hua SY, Lee JH, Charles L, Chitkara D, Usiskin K, Colombel JF, Laine L, Danese S; True North Study Group. Sandborn WJ, et al. N Engl J Med. 2021 Sep 30;385(14):1280-1291. doi: 10.1056/NEJMoa2033617. N Engl J Med. 2021. PMID: 34587385 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

307 results

Search Page

Filters